Preventing early-onset group B streptococcal sepsis: clinical risk factor-based screening or culture-based screening?
Two strategies are available for prevention of early-onset group B streptococcal (GBS) sepsis ¬- clinical risk factor-based screening and routine culture-based screening of pregnant women for GBS colonisation. In our hospital, we switched from the former to the latter approach in 2014. We compared the incidence of early-onset GBS sepsis during 2001-2015 between infants born to pregnant women who were screened for GBS colonisation and those born to women who were not. Among 41,143 live births, there were nine cases of early-onset GBS sepsis. All infants with GBS sepsis were born to pregnant women who were not screened for GBS colonisation. Early-onset GBS sepsis incidence among infants of women not screened for GBS colonisation was 0.41 per 1,000 live births (95% confidence interval [CI] 0.19-0.77) when compared to infants of screened women, for whom the sepsis incidence was 0.0 per 1,000 live births (95% CI 0.0-0.19) (p = 0.005). Our data suggests that routine culture-based screening of pregnant women for GBS colonisation is a better preventive strategy for early-onset GBS sepsis in neonates when compared to clinical risk factor-based screening.